What are the recommended levocetirizine (Xyzal) doses for adults, children (6 months–5 years, 6–11 years, ≥12 years), and patients with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Xyzal (Levocetirizine) Dosing

For adults and children ≥12 years, use 5 mg once daily; children 6-11 years require 2.5 mg once daily; infants 6-11 months need 1.25 mg once daily, and children 1-5 years need 1.25 mg twice daily; patients with renal impairment require dose reduction by half, and those with severe renal impairment (CrCl <10 mL/min) should avoid levocetirizine entirely. 12

Standard Dosing by Age

Adults and Adolescents (≥12 years)

  • Standard dose: 5 mg once daily in the evening 1
  • For less severe symptoms, 2.5 mg once daily may be appropriate 1
  • Do not exceed 5 mg in 24 hours 1

Children 6-11 Years

  • Dose: 2.5 mg (½ tablet) once daily in the evening 1
  • Do not exceed 2.5 mg in 24 hours 1
  • This dosing is supported by efficacy data showing significant symptom improvement in perennial allergic rhinitis 3

Children 1-5 Years

  • Dose: 1.25 mg (0.125 mg/kg) twice daily 45
  • This regimen demonstrated excellent pharmacokinetic/pharmacodynamic profile with 100% median wheal inhibition 5
  • Well tolerated in clinical trials with safety profile similar to placebo 4

Infants 6-11 Months

  • Dose: 1.25 mg once daily 4
  • Safety established in controlled trials, though TEAEs were similar between levocetirizine and placebo 4

Children <6 Months

  • Do not use 1

Renal Impairment Dosing

Critical adjustment required: Levocetirizine is renally eliminated, making dose modification essential in renal dysfunction 222

Moderate Renal Impairment (CrCl 10-50 mL/min)

  • Halve the standard dose 222
  • Example: Adults would receive 2.5 mg once daily instead of 5 mg

Severe Renal Impairment (CrCl <10 mL/min)

  • Avoid levocetirizine entirely 222
  • The drug should not be used in this population due to accumulation risk

Patients with Kidney Disease

  • Do not use per FDA labeling 1

Elderly Patients (≥65 Years)

  • Consult physician before use 1
  • Consider lower doses due to age-related decline in renal function
  • Start with 2.5 mg daily if renal function is compromised

Key Clinical Considerations

Timing matters: Levocetirizine is taken once daily in the evening for optimal symptom control during typical peak allergy hours 1. The drug reaches peak plasma levels within 1 hour in children 5, providing rapid onset of action.

Dose escalation in refractory cases: While the FDA label specifies maximum doses, clinical practice guidelines note it has become common to increase antihistamine doses above manufacturer recommendations when benefits outweigh risks, though this is off-label 22. However, start with standard dosing first.

Common pitfall: Failing to adjust for renal function is the most critical error. Always calculate creatinine clearance before prescribing, as levocetirizine accumulation in renal impairment can increase adverse effects without additional benefit 222.

Pregnancy and lactation: Avoid if possible, particularly in first trimester, though no human teratogenicity has been demonstrated 22. Cetirizine (the racemic mixture) is FDA Pregnancy Category B, suggesting levocetirizine carries similar risk profile.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.